VaccinesInfant vaccination schedule — how many injections are too many?
- Stowarzyszenie STOP NOP — Dr n.med. Dorota Sienkiewicz „Bezpieczne szczepienia” – alternatywny kalendarz szczepień – Ogólnopolskie Stowarzyszenie Wiedzy o Szczepieniach "STOP NOP"
- Stowarzyszenie STOP NOP — Szczepienia – poznaj ich ryzyko i skuteczność – Ogólnopolskie Stowarzyszenie Wiedzy o Szczepieniach "STOP NOP"
- DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure. · Expert Rev Vaccines 2023
- Orthomolecular Medicine News Service — Vaccine Science and Myth
- Orthomolecular Medicine News Service — Born Defenseless: Why Infant Liver Maturity May Be the Missing Piece in Understanding Vaccine Safety, SIDS, and NDDs
- Orthomolecular Medicine News Service — Positive Correlation between the Number of Vaccine Doses and Infant Mortality
The STOP NOP Association says that by six months of age, an infant receives a total of 24–26 doses of foreign antigens.
- In the first year of life, the schedule described by the association includes nine recommended vaccinations.
- STOP NOP’s proposal limits the number of types of vaccines given on one day to three.
What the authors write
Stowarzyszenie STOP NOP
The STOP NOP Association’s proposal limits the number of types of vaccines given on one day to three.
„administering no more than three types of vaccines on a single day; ? not administering vaccines containing live viruses, or administering them one at a time at safe intervals; ? making monovalent vaccines available; ? requiring the vaccinating doctor to conduct an initial interview with the parents about allergies, asthma, other autoimmune diseases, and post-vaccination complications among family members, to help predict whether the child might have serious post-vaccination reactions (such a child should have an individual, very cautious vaccination schedule drawn up);”podanie maksymalnie trzech rodzajów szczepionek w jednym dniu; ? rezygnacja z podawania szczepionek zawierających żywe wirusy lub podawanie ich pojedynczo w bezpiecznych odstępach czasu; ? udostępnienie szczepionek monowalentnych; ? zobowiązanie szczepiącego lekarza do przeprowadzenia wstępnego wywiadu z rodzicami odnośnie alergii, astmy i innych chorób typu autoimmunologicznego oraz powikłań poszczepiennych u członków rodziny, co pozwoli przewidzieć, czy u danego dziecka mogą wystąpić groźne reakcje poszczepienne (takie dziecko powinno mieć opracowany indywidualny, bardzo ostrożny program szczepień);
Stowarzyszenie STOP NOP
According to the STOP NOP Association, by six months of age an infant receives a total of 24–26 doses of foreign antigens.
„Children up to 6 months of age are also offered recommended vaccinations against rotavirus and pneumococci (2?3 doses). Together with the tuberculosis and hepatitis B vaccinations given on the first day of life, an infant receives 24?26 doses of foreign antigens.”Dziecku do 6 miesiąca życia proponowane są także zalecane szczepienia przeciwko rotawirusom i pneumokokom (2?3 dawki). Łącznie z przeprowadzanym w pierwszej dobie życia szczepieniem przeciw gruźlicy i WZW B niemowlę otrzymuje 24?26 dawek antygenu obcogatunkowego.
Stowarzyszenie STOP NOP
The STOP NOP Association describes infants as receiving nine recommended vaccinations in the first year of life.
„In the first year of life, they receive nine recommended vaccinations, and at 18 months ? MMR. The acellular pertussis vaccine (DTaP) and IPV are used.
Figure 2. Tuberculosis incidence in Germany in 1949?1987 (source: Statistisches Bundesamt Wiesbaden)
Figure 3.”W pierwszym roku życia otrzymują dziewięć zalecanych szczepień, a w 18 miesiącu ? MMR. Stosowana jest bezkomórkowa szczepionka przeciw krztuścowi (DTaP) oraz IPV.
Rycina 2. Zachorowalność na gruźlicę w Niemczech w latach 1949?1987 (źródło: Statistisches Bundesamt Wiesbaden)
Rycina 3.
Stowarzyszenie STOP NOP
The Polish schedule described by the STOP NOP Association provides for the first three DTwP doses to be given from 6–8 weeks of age, at intervals of 6–8 weeks.
„According to the vaccination schedule in force in Poland, infants receive the first three DTwP doses from 6?8 weeks of age, at intervals of 6?8 weeks, a fourth dose at 16?18 months of age, and a DTaP booster dose at 6 years of age. Most of these are therefore less safe whole-cell vaccines.”Według obowiązującego w Polsce kalendarza szczepień, niemowlęta otrzymują trzy pierwsze dawki DTwP od 6?8 tygodnia życia co 6?8 tygodni, 4 dawkę w 16?18 miesiącu życia i dawkę przypominającą DTaP w 6 roku życia, a więc większość stanowią mniej bezpieczne szczepionki całokomórkowe.
Stowarzyszenie STOP NOP
The STOP NOP Association writes that schedules include more and more components and that multiple antigens are often given at the same time, which it links to a higher risk of adverse effects.
„In developed countries, childhood schedules for mandatory and recommended vaccinations include more and more components, with particular emphasis on giving multiple antigens at the same time in combination form. While this approach offers many benefits, it also carries an increased risk of adverse effects, whose immunopathogenesis is not fully understood in many cases (Ward 2000).”W krajach rozwiniętych kalendarze obowiązkowych i zalecanych szczepień ochronnych dla dzieci zawierają coraz więcej elementów, przy czym kładzie się szczególny nacisk na jednoczesne podawanie wielu antygenów w formie skojarzonej. Ten kierunek, dający z jednej strony wiele korzyści, z drugiej niesie zwiększone ryzyko działań niepożądanych, których immunopatogeneza w wielu wypadkach nie jest do końca wyjaśniona (Ward 2000).
Stowarzyszenie STOP NOP
According to a report cited by the STOP NOP Association, key elements of the schedule, including the number and frequency of vaccinations, have not been systematically studied.
„Although new vaccines are assessed in the context of the overall vaccination schedule in place when the vaccine is studied, individual elements of that schedule are not reassessed after it is changed to include another vaccine. Thus, key elements of the overall schedule—the number, frequency, timing, order, and age at which vaccines are given—have not been systematically studied in clinical trials;? ? Institute of Medicine (2013)23”Choć nowe szczepionki ocena się w kontekście ogólnego harmonogramu szczepień istniejącego w czasie badania tejże szczepionki, poszczególne elementy tego kalendarza nie są poddawane ocenie po jego zmianie uwzględniającej dodanie kolejnej szczepionki. Zatem, kluczowe elementy całego kalendarza – liczba, częstotliwość, czas, kolejność i wiek podawania szczepień – nie zostały poddane badaniom systematycznym w badaniach klinicznych;? ? Institute of Medicine (2013)23
Research from PubMed · Europe PMC
We selected 1 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 5 194.
The Hexaxim combination vaccine protects against six diseases with fewer injections, and a review found a favorable safety profile and good immune response.
Aim of the study: Hexaxim® is a fully liquid, hexavalent combination vaccine that provides immunization against diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis B, and invasive diseases caused by Haemophilus influenzae type b. Combination vaccines such as Hexaxim reduce the number of injections needed, improving both vaccination compliance and operational efficiency.
DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure. · Expert Rev Vaccines 2023
Money for the studycompany or manufacturer · Sanofi
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?YES
Type of studydiscussion of other studies
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Orthomolecular Medicine News Service Opinion material
„This makes a nonsense of Big Pharma's advice to vaccinate all members of a new infant's family to protect the infant from infection This "cocooning" strategy increases the risk of infant infection. Herd immunity cannot apply to vaccines which afford protection against bacterial endotoxins and so herd immunity cannot possibly occur with tetanus and diphtheria vaccines. The spread of diphtheria has been controlled by isolating sufferers and treating them with antibiotics. Herd immunity is impossible to achieve with influenza vaccine because the flu virus is constantly evolving and changes every year.”This makes a nonsense of Big Pharma's advice to vaccinate all members of a new infant's family to protect the infant from infection This "cocooning" strategy increases the risk of infant infection. Herd immunity cannot apply to vaccines which afford protection against bacterial endotoxins and so herd immunity cannot possibly occur with tetanus and diphtheria vaccines. The spread of diphtheria has been controlled by isolating sufferers and treating them with antibiotics. Herd immunity is impossible to achieve with influenza vaccine because the flu virus is constantly evolving and changes every year.
Orthomolecular Medicine News Service Opinion material
„This compounding effect may explain vaccine-associated regression, seizures, or SIDS-like events in genetically or nutritionally vulnerable infants. Yet, current public health policies rarely factor in these biochemical realities. 🔍 Factoring New Risk Dimensions into Vaccine Policy A comprehensive risk-benefit analysis of early-life vaccination should not ignore: The prevalence of Autism Spectrum Disorder (ASD), now 1 in 31 children in the U.S. [18]. The plausible link between SIDS and immature CYP450 enzyme systems and 5-HT brainstem networks involved in autonomic control [19,20]. Statistically significant findings from Mawson et al.”This compounding effect may explain vaccine-associated regression, seizures, or SIDS-like events in genetically or nutritionally vulnerable infants. Yet, current public health policies rarely factor in these biochemical realities. 🔍 Factoring New Risk Dimensions into Vaccine Policy A comprehensive risk-benefit analysis of early-life vaccination should not ignore: The prevalence of Autism Spectrum Disorder (ASD), now 1 in 31 children in the U.S. [18]. The plausible link between SIDS and immature CYP450 enzyme systems and 5-HT brainstem networks involved in autonomic control [19,20]. Statistically significant findings from Mawson et al.
Orthomolecular Medicine News Service Opinion material
„Miller and Goldman conclude their recently published 2023 study [5] by reaffirming the main finding in their original 2011 study: There is a positive correlation between infant vaccines and infant mortality rates. This relationship is most pronounced in analyses of the most highly developed homogenous nations but is attenuated in background noise in analyses of nations with heterogeneous socioeconomic variables. Health authorities in all nations have an obligation to determine whether their immunization schedules are achieving desired goals. More investigations into the health outcomes of vaccinated vs.”Miller and Goldman conclude their recently published 2023 study [5] by reaffirming the main finding in their original 2011 study: There is a positive correlation between infant vaccines and infant mortality rates. This relationship is most pronounced in analyses of the most highly developed homogenous nations but is attenuated in background noise in analyses of nations with heterogeneous socioeconomic variables. Health authorities in all nations have an obligation to determine whether their immunization schedules are achieving desired goals. More investigations into the health outcomes of vaccinated vs.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.